Literature DB >> 19339810

Fundus autofluorescence before and after photodynamic therapy for chronic central serous chorioretinopathy.

Emin Ozmert1, Figen Batioğlu.   

Abstract

BACKGROUND: To determine the effect of photodynamic therapy (PDT) in chronic central serous chorioretinopathy (CSCR) and to describe fundus autofluorescence (AF) patterns before and after PDT.
METHODS: Seven eyes of 7 patients with chronic CSCR were included. Patients underwent complete ophthalmic examination and macular optical coherence tomography (OCT) scans were taken. Fluorescein and indocyanine green angiographies and fundus AF images were obtained by Heidelberg Retinal Angiography 2 (HRA2). PDT was performed according to the standard TAP protocol on the site of leakage area and submacular fluid. The mean follow-up period was 5.4 months.
RESULTS: Submacular fluid disappeared in all eyes 1 month after PDT and there was no recurrence during the follow-up. Visual acuity increased two or more lines in 5 eyes. Hyperautofluorescence in the area of previous retinal detachment significantly increased in the first month of PDT compared to preoperative findings. After the first month during the follow-up, increased AF in the area of previous retinal elevation returned to the baseline intensity.
CONCLUSION: PDT of CSCR may result with resolution of subretinal fluid and visual improvement. Fundus AF may be an additional tool for monitoring the functional status of retinal pigment epithelium. (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19339810     DOI: 10.1159/000210386

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  17 in total

1.  Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy.

Authors:  M J Koss; I Beger; F H Koch
Journal:  Eye (Lond)       Date:  2011-11-11       Impact factor: 3.775

2.  Acute central serous chorioretinopathy: a correlation study between fundus autofluorescence and spectral-domain OCT.

Authors:  Pierluigi Iacono; Parodi Maurizio Battaglia; Alexandros Papayannis; Carlo La Spina; Monica Varano; Francesco Bandello
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-01-08       Impact factor: 3.117

Review 3.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

4.  Comparison of autofluorescence and optical coherence tomography findings in acute and chronic central serous chorioretinopathy.

Authors:  Mehmet Yasin Teke; Ufuk Elgin; Pinar Nalcacioglu-Yuksekkaya; Emine Sen; Pinar Ozdal; Faruk Ozturk
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

5.  [Treatment of central serous chorioretinopathy: MicroPulse photocoagulation versus bevacizumab].

Authors:  I Beger; M J Koss; F Koch
Journal:  Ophthalmologe       Date:  2012-12       Impact factor: 1.059

6.  Vascular and structural alterations of the choroid evaluated by optical coherence tomography angiography and optical coherence tomography after half-fluence photodynamic therapy in chronic central serous chorioretinopathy.

Authors:  Sibel Demirel; Gökçen Özcan; Özge Yanık; Figen Batıoğlu; Emin Özmert
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-01-07       Impact factor: 3.117

Review 7.  Fundus autofluorescence imaging: systematic review of test accuracy for the diagnosis and monitoring of retinal conditions.

Authors:  G K Frampton; N Kalita; L Payne; J L Colquitt; E Loveman; S M Downes; A J Lotery
Journal:  Eye (Lond)       Date:  2017-03-10       Impact factor: 3.775

Review 8.  Photodynamic therapy for central serous chorioretinopathy.

Authors:  O C Erikitola; R Crosby-Nwaobi; A J Lotery; S Sivaprasad
Journal:  Eye (Lond)       Date:  2014-06-20       Impact factor: 3.775

9.  Fundus autofluorescence imaging patterns in central serous chorioretinopathy according to chronicity.

Authors:  W J Lee; J-H Lee; B R Lee
Journal:  Eye (Lond)       Date:  2016-06-10       Impact factor: 3.775

Review 10.  Verteporfin PDT for non-standard indications--a review of current literature.

Authors:  Wai Man Chan; Tock-Han Lim; Alfredo Pece; Rufino Silva; Nagahisa Yoshimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-17       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.